Sei sulla pagina 1di 6

REVIEW

URRENT
C
OPINION

Health benefits of cocoa


Rabia Latif

Purpose of review
In modern society, cocoa is being eaten as a confectionery, contrary to its medicinal use in the past.
However, since the last decade, there has been a revival of talks about cocoas health beneficial effects.
Development has been made at the molecular level recently. This review discusses the recent progresses on
potential health benefits of cocoa and/or its derivatives, with a focus on the areas that have been paid
little attention so far, such as the role of cocoa in immune regulation, inflammation, neuroprotection,
oxidative stress, obesity, and diabetes control.
Recent findings
Thanks to the advancement in analytical technologies, the cocoas metabolic pathways have now been
properly mapped providing essential information on its roles. Cocoa helps in weight loss by improving
mitochondrial biogenesis. It increases muscle glucose uptake by inserting glucose transporter 4 in skeletal
muscles membrane. Because of its antioxidant properties, cocoa offers neuron protection and enhances
cognition and positive mood. It lowers immunoglobulin E release in allergic responses. It can affect the
immune response and bacterial growth at intestinal levels. It reduces inflammation by inhibiting nuclear
factor-kB.
Summary
Keeping in view the pleiotropic health benefits of cocoa, it may have the potential to be used for the
prevention/treatment of allergies, cancers, oxidative injuries, inflammatory conditions, anxiety,
hyperglycemia, and insulin resistance.
Keywords
cocoa flavonoids, cognition, immune system, inflammation, insulin resistance, obesity, oxidative stress

INTRODUCTION
Cocoa and cocoa-based products such as chocolate
are one of the major natural sources of dietary flavonoids because of its high content of polyphenols,
epicatechin, catechin primarily and their oligomers,
and the procyanidins. Over the last decade, cocoa
research has become the center of growing attention.
The cardiovascular effects of chocolate/cocoa have
been investigated and reviewed thoroughly [1 ], and
even found to be cost-effective [2 ]; however, there is
dearth of studies dealing with other beneficial effects
such as immune modulation, antioxidative, antiinflammatory, neuroprotective, insulin resistance,
obesity, and so on. The aim of this review is to
bring into the limelight these unvisited, not too well
known effects and summarize the most recent evidence of the effects of chocolate/cocoa on body
systems other than cardiovascular.
&

&

EFFECTS OF CHOCOLATE ON IMMUNE


SYSTEM
The cocoa/chocolate influences multiple aspects of
the immune system. The recent advances in this

context are the effect of cocoa/chocolate on allergy


and intestinal immune system.

ALLERGY
Allergy is characterized by dysregulated immune
response in atopic individuals. Various nutritional
interventions against allergic diseases have been
investigated recently, coca being one of these
emerging nutraceuticals [3]. In a recent experimental study of rat allergic model, cocoa diet caused
considerably lower concentrations of total serum
immunoglobulin E (IgE), decreased tumor necrosis
factor, and interleukin (IL)-10, signifying a possible

Department of Physiology, College of Medicine, University of Dammam,


Dammam, Kingdom of Saudi Arabia
Correspondence to Dr Rabia Latif, MBBS, MPhil, PhD, Department of
Physiology, College of Medicine, University of Dammam, Dammam,
Kingdom of Saudi Arabia. Tel: +966 596 212 648; e-mail: dr.rabialatif
@gmail.com, rlhussain@ud.edu.sa
Curr Opin Clin Nutr Metab Care 2013, 16:669674
DOI:10.1097/MCO.0b013e328365a235

1363-1950 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

www.co-clinicalnutrition.com

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Functional foods and dietary supplements

KEY POINTS
 Cocoa reduces body weight by increasing
mitochondrial biogenesis, capillarity, and
muscular performance.
 Cocoa protects against insulin resistance and
hyperglycemia by inserting glucose transporter 4
(GLUT4) in skeletal muscle membranes.
 Cocoa causes considerably lower concentrations of
total serum IgE, decreased tumor necrosis factor, and
IL-10, signifying a possible role for cocoa flavonoids in
the treatment of allergic disorders.
 Cocoa has a positive effect on mood, neural efficiency,
and may enhance cognition.
 Cocoa reduces inflammatory potential by inhibiting
nuclear factor-kB (NF-kB).
 The cocoa-induced immune modulation may be
important in cancers, inflammation, diseases like celiac
or food allergies, and autoimmune pathogenesis.

immunity in autoimmune diseases and allograft


transplantation) percentage [9]. This immune
modulation may be important in cancers, inflammation, diseases like celiac or food allergies, and
autoimmune pathogenesis.

OXIDATIVE STRESS
There is a strong evidence for antioxidant effects of
cocoa in a variety of in-vitro studies. Recently, a
study has revealed that procyanidin flavonoids from
cocoa have the potential to protect colonic cells
from oxidative stress and chemical-induced injury
by modulating major antioxidant/detoxificant
enzymes involved in intestinal protection [10 ].
However, the antioxidant efficacy of flavonoids
in vivo is less recognized. Two recent studies have
investigated the effects of cocoa supplementation
in vivo in rat models of adjuvant and autoimmune
arthritis [11 ,12]. Cocoa supplementation resulted
in increased splenic catalase and less reactive oxygen
species (ROS) synthesis by macrophages [11 ]. This
decreased synthesis of ROS is most likely due to
cocoa flavonoids free radical quenching activity.
Cheng et al. [13 ] suggested that catechin supplementation significantly inhibited oxidative damage
and overturned the impairment of the antioxidant
system in the intestinal mucosa of Ketoprofenexposed rats. Cheng et al. showed that catechin,
one of the constituents of cocoa, effectively prevents
Ketoprofen-induced intestinal epithelial cell injury
and induces expression of heme oxygenase-1 (an
antioxidant enzyme associated with protection of
intestines) via modulation of nuclear factor erythroid 2-related factor 2 (a transcription factor that
regulates antioxidant enzymes) protein translocation. These findings strongly support the potential
use of cocoa as a dietary preventive agent against
intestinal injuries induced by oxidative stress.
&

&

&

role for cocoa flavonoids in the treatment of allergic


disorders [4 ].
&

INTESTINAL IMMUNE SYSTEM AND


MICROBIOTA
In the gut immune system, chocolate/cocoa alters
Toll-like receptors expression and downregulates
intestinal IgA by decreasing:
(1) IL-6, a cytokine essential for the conversion of
B cells to IgA-secreting cells;
(2) chemokine ligands and its chemokine receptors,
required for promoting cell recruitment in
intestinal lamina propria; and
(3) genes associated with gut homing of IgA-secreting cells [5 ].

&&

&

Cocoa procyanidins and fiber reach the colon


intact and act as a bacterial growth substrate inside
the colon. Long-term cocoa intake can even modify
microbiota composition and immune response at
intestinal level [6], excellently reviewed recently
[7 ]. It results in a differential Toll-like receptors
pattern and a decrease in the intestinal IgA secretion
and IgA-coating bacteria associated with a significant decrease in the proportion of Bacteroides,
Clostridium, and Staphylococcus genera in the feces
[8].
The cocoa intake also reduces helper and regulatory T cells and increases natural killer T cell
(T lymphocytes that promote cellular immunity
in tumors and infections, and suppresses cellular
&

670

www.co-clinicalnutrition.com

NEUROPROTECTIVE EFFECTS
The neuroprotective effects of cocoa have been
recently reviewed by Nehlig [14 ].
&

MOOD
The link between cocoa consumption and cardiovascular health is well documented. Good cardiovascular health is related to better cognitive
performance [15]. Cocoa flavonols have been shown
to significantly reduce mental fatigue and improve
cognitive thinking during sustained mental effort
[16]. Chocolate also reduces symptoms of anxiety
and depression in patients with chronic fatigue [17].
Recently, direct effects of high and low cocoa
Volume 16  Number 6  November 2013

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Health benefits of cocoa Latif

polyphenols on cognitive performance and mood in


healthy individuals have been revealed through a
double-blind, placebo-controlled study using highly
validated, computerized cognitive test battery
[18 ]. Cocoa improved self-rated calmness and contentedness following 30 days of treatment, most
probably by known actions of polyphenols on GABA
receptors [19] and by upregulating tryptophan
metabolism leading to the production of serotonin:
a calming neurotransmitter [20 ]. Cognitive performance was not altered significantly, a finding
contrary to Scholey et al. [16]. Pase et al. [18 ]
suggested that improved cognition following cocoa
may only arise under situations of high stress and
calm feelings perhaps may not lead to cognitive
enhancement. Another hypothesis was that the
participants were highly educated (average education
level was 16 years) and there was little scope for
cognitive enhancement as compared with participants who have suboptimal cognitive performance
[19].
&&

&&

&&

COGNITION
A note recently published in New England Journal of
Medicine reported a close, significant linear correlation between chocolate consumption per capita
and the number of Nobel laureates per in a total of
23 countries [21 ].
In another study, steady state visually evoked
potentials measured in response to a spatial working
memory task in cocoa supplemented group exhibited
some significant potential differences, suggesting
that cocoa supplementation may improve neural
efficiency [22 ]. The underlying mechanism of
enhanced neural efficiency might be improved vascular function and/or antioxidant processes within
the brain associated with cocoa intake.
&&

&

ALZHEIMERS DISEASE
Alzheimers disease is a neurodegenerative disorder
characterized pathologically by plaques made up
of amyloid beta peptide (Ab). Cocoa has been
shown to reduce Ab toxicity in an animal model
of Alzheimers disease by inhibiting oligomerization
through its antioxidant activity and upregulating
[20 ] the following pathways:
&&

(1) Pyruvate pathway in which pyruvate changes


to acetyl CoA, a key substance for the synthesis
of ATP and acetylcholine. Downregulation
of pyruvate pathway is associated with the
reduction of acetylcholine, ATP production,
glycolysis, mitochondrial dysfunction, and
neuronal death the features that are all present
in Alzheimers disease [23,24].

(2) Proteosome, a large protein complex that maintains protein homeostasis and inhibits Ab
peptide aggregation.
(3) Citric acid cycle pathway that is downregulated
in Alzheimers disease.
Thanks to the advancement in analytical technologies, the cocoas metabolic pathways have now
been properly mapped providing essential information on its roles in Alzheimers disease. Recently,
the effect of cocoa polyphenolic extract on a human
Alzheimers disease in-vitro model has been investigated, which revealed that cocoa polyphenols triggers neuroprotection by activating brain-derived
neurotrophic factor (BDNF) survival pathway, both
on Ab plaque-treated cells and on Ab oligomerstreated cells [25 ]. BDNF is a neurotrophin required
for the development and maintenance of the
nervous system. It plays an important role in cognition, learning, and memory formation and has
also been implicated in Alzheimers disease [26].
BDNF-boosting neuroprotective effects in vitro
suggest that the cocoa or its derivatives may have
a therapeutic potential for Alzheimers disease.
&&

STROKE
A recent study has examined the association
between chocolate consumption and risk of stroke
in Swedish men [27 ]. Previous studies have investigated this association, either in women only or in
both men and women [28,29]. Larsson et al. [27 ]
planned a large-scale (37 103 participants) and
longer duration (over 10 years) study in which
chocolate consumption was assessed using a foodfrequency questionnaire and stroke cases were
identified through a hospital discharge registry. It
was found that men, who ate the largest amount of
chocolate, had a 17% lower risk of stroke compared
to those who did not consume any chocolate.
Larsson et al. also conducted a meta-analysis using
the search terms chocolate and stroke and identified five studies. The analysis of these studies
showed an overall 19% decreased risk of stroke for
individuals with highest chocolate consumption
compared to nonchocolate consumers. The mechanisms responsible for this observed inverse association between chocolate intake and stroke risk may
include antioxidant, antiplatelet, and anti-inflammatory effects of chocolate flavonoids.
&

&

INFLAMMATION
Cocoa supplementation results in less secretion
of inflammatory mediators from peritoneal macrophages [12], in line with the previous studies

1363-1950 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

www.co-clinicalnutrition.com

671

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Functional foods and dietary supplements

documenting anti-inflammatory effects of cocoa in


healthy animals [30]. However, it [12] was unique in
the sense that it showed anti-inflammatory effects
of orally taken cocoa in a pathological state.
The suggested mechanism behind cocoa-induced
reduced inflammatory potential is inhibition of
NF-kB [31 ], which is a transcriptional modulator
of genes involved in inflammation. NF-kB plays a
pivotal role in the development of inflammatory
diseases and regarded as a key therapeutic target at
the moment [32]. It is present in the cell cytoplasm
as an inactive form. Upon activation, it migrates to
the nucleus to modulate the transcription of the
inflammatory cytokines such as tumor necrosis
factor-a (TNF-a) and adhesion molecules. Cocoa
flavonoids have been shown to prevent colon
inflammation in a rat model of colon cancer and
in TNF-a-stimulated Caco-2 cells (a well established
in-vitro model of human intestines), by decreasing
the nuclear levels of NF-kB and the expression of
proinflammatory enzymes such as cyclo-oxygenase2 and inducible nitric oxide [33 ]. Rodrguez-Ramiro
et al. [10 ,33 ] elucidated the mechanisms involved
at molecular level that turned out to be inhibition of
&

&

&

&

NF-kB translocation and c-Jun N-terminal kinases


(JNK) phosphorylation. Hence, cocoa could be effective in the dietary prevention of intestinal inflammation and related cancer development.

OBESITY, HYPERGLYCEMIA, AND INSULIN


RESISTANCE
Hyperglycemia and obesity are closely related to
insulin resistance and type-2 diabetes mellitus.
Chocolate products are often high in sugar and
fat, leading to the assumption that eating chocolate
enhances BMI. However, a recent study has refuted
this belief by showing that frequency of chocolate
consumption is significantly related to lower BMI
after adjusting for age and sex [34 ]. This study does
not preclude the likelihood of some chocolate products or chocolate consumption profiles doing so.
Certainly this correlation does not establish causation. However, compatible experimental findings in
animal studies suggest the association could be
causal [35,36] and cocoa may reduce body weight
without changing calories or exercise by increasing
mitochondrial biogenesis, capillarity, and muscular
&&

Cocoa

Inhibition of lipases

Plasma adiponectin

AMP-K

UCP and PGC-1

Absorption of dietary fat

GLUT4

Fatty acid oxidation


Lipogenesis

Fecal lipid output

Mitochondrial biogenesis

Glucose uptake

Blood glucose

Body weight

Serum lipids

Insulin sensitivity

FIGURE 1. Proposed mechanism of cocoa-induced weight loss and improved insulin sensitivity. AMP-Ka, AMP activated
protein kinase a; GLUT4, glucose transporter 4; UCP, uncoupling protein; PGC-1a, proliferator-activated receptor c
coactivator-1a.
672

www.co-clinicalnutrition.com

Volume 16  Number 6  November 2013

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Health benefits of cocoa Latif

performance. Underlying mechanism behind


cocoa-induced increased mitochondrial biogenesis
is high plasma adiponectin levels that then cause
activation of AMP-activated protein kinase (AMPKa)
in skeletal muscle, liver, and adipose tissue [37 ].
AMPKa regulates intracellular glucose and lipid
metabolism by translocating GLUT4 to the plasma
membrane in skeletal muscle and brown adipose
tissue; thus, preventing hyperglycemia and insulin
resistance. The activation of AMPKa also promotes
the expression of uncoupling protein (UCP); a family
of proton transporters located in the mitochondrial
inner membrane and causes increased thermogenesis
and energy expenditure and proliferator-activated
receptor c coactivator-1a (PGC-1a) in skeletal
muscle, adipose tissue and liver, thus preventing
obesity by increasing energy expenditure and/or
thermogenesis. Activation of AMPKa also helps to
prevent obesity by inhibiting lipogenesis, stimulating fatty acid oxidation in the liver and skeletal
muscles [38].
Cocoa also inhibits dietary fat absorption by
inhibiting the activity of pancreatic lipase and
secreted phospholipase A2 [39] leading to a
reduction in rate of body weight gain along with
an increase in fecal lipid output [40 ]. Suggested
mechanism of the role of cocoa in preventing
obesity, hyperglycemia, and insulin resistance has
been summarized in Fig. 1.
Min et al. [41 ] suggested that cocoa can avert
obesity by targeting insulin receptors in a tissuespecific manner. Min et al. [41 ] showed that cocoa
inhibits early stage of adipogenesis in preadipocytes
by decreasing insulin receptor kinase activity via
direct binding.
&

&

&

&

CONCLUSION
Chocolate/cocoa therapy or its derivatives could
have a role in the prevention of, or offer a substitute
to or be used to complement drug therapy for
diseases such as inflammation, immune dysregulation/autoimmune pathogenesis, allergies, anxiety,
hyperglycemia, obesity, and insulin resistance.
However, this needs extensive interventional
studies evaluating the effects of cocoa products in
human populations as clinical evidence supporting
the health benefits of cocoa in humans is insufficient. Most reports documenting chocolates
beneficial effects are coming from animal research
that warrants extreme care in extrapolating the
results to human populations.
Acknowledgements
None.

Conflicts of interest
There are no conflicts of interest.

REFERENCES AND RECOMMENDED


READING
Papers of particular interest, published within the annual period of review, have
been highlighted as:
&
of special interest
&& of outstanding interest
1. Hooper L, Kay C, Abdelhamid A, et al. Effects of chocolate, cocoa, and flavan&
3-ols on cardiovascular health: a systematic review and meta-analysis of
randomized trials. Am J Clin Nutr 2012; 95:740751.
This review systematically reviews the effects of chocolate, cocoa, and flavan-3-ols
on major cardiovascular disease risk factors.
2. Zomer E, Owen A, Magliano DJ, et al. The effectiveness and cost effective&
ness of dark chocolate consumption as prevention therapy in people at high
risk of cardiovascular disease: best case scenario analysis using a Markov
model. BMJ 2012; 344:e3657.
First study to show that cocoa consumption could be an effective and cost
effective primary prevention strategy for those with cardiovascular risk factors
and has the potential to prevent adverse cardiovascular events over the long term.
3. Kalliomki M, Antoine JM, Herz U, et al. Guidance for substantiating the
evidence for beneficial effects of probiotics: prevention and management
of allergic diseases by probiotic. J Nutr 2010; 140:S713S721.
4. Abril-Gil M, Massot-Cladera M, Perez-Cano FJ, et al. A diet enriched with
&
cocoa prevents IgE synthesis in a rat allergy model. Pharmacol Res 2012;
65:603608.
First study to show antiallergic effects of cocoa in rat allergic model. Previous
studies have reported the effects of cocoa on immune status of healthy rats.
5. Perez-Berezoa T, Franterm A, Castellote C, et al. Mechanisms involved in
&
down-regulation of intestinal IgA in rats by high cocoa intake. J Nutr Biochem
2012; 23:838844.
First study to reveal the mechanism behind cocoa-induced downregulation of
intestinal IgA in rats.
6. Hayek N. Chocolate, gut microbiota, and human health. Front Pharmacol
2013; 4:11.
7. Perez-Cano FJ, Massot-Cladera M, Franch A, et al. The effects of cocoa on the
&
immune system. Front Pharmacol 2013; 4:71.
This study reviews the influence of cocoa or its flavonoids on innate and acquired
immunity and suggests that cocoa diet may be beneficial in certain immune
disorders.
8. Massot-Cladera M, Berezo TP, Franch A, et al. Cocoa modulatory effect on rat
faecal microbiota and colonic crosstalk. Arch Biochem Biophys 2012;
527:105112.
9. Ramos-Romero S, Perez-Cano FJ, Castellote C, et al. Effect of cocoaenriched diets on lymphocytes involved in adjuvant arthritis in rats. Br J Nutr
2012; 107:378387.
10. Rodrguez-Ramiro I, Ramos S, Bravo L, et al. Procyanidin B2 induces Nrf2
&
translocation and glutathione S-transferase P1 expression via ERKs and p38MAPK pathways and protect human colonic cells against oxidative stress. Eur
J Nutr 2012; 51:881892.
This study shows that Procyanidin flavonoids from cocoa have the potential to
protect colonic cells from oxidative stress and chemical-induced injury by modulating major antioxidant/detoxificant enzymes involved in intestinal protection.
11. Ramos-Romeroa S, Perez-Cano FJ, Ramiro-Puiga E, et al. Cocoa intake
&
attenuates oxidative stress associated with rat adjuvant arthritis. Pharmacol
Res 2012; 66:207212.
First study to investigate the effects of cocoa supplementation on oxidant and
antioxidant status of rats with adjuvant arthritis.
12. Ramos-Romero S, Perez-Cano FJ, Perez-Berezo T, et al. Effect of a cocoa
flavonoid-enriched diet on experimental autoimmune arthritis. Br J Nutr 2012;
107:523532.
13. Cheng YT, Wu CH, Ho CY, Yen GC. Catechin protects against ketoprofen&&
induced oxidative damage of the gastric mucosa by up-regulating Nrf2 in vitro
and in vivo. J Nutr Biochem 2013; 24:475483.
First study to support the potential use of cocoa as a dietary preventive agent
against gastric/intestinal injuries induced by oxidative stress or NSAIDs.
14. Nehlig A. The neuroprotective effects of cocoa flavonol and its influence on
&
cognitive performance. Br J Clin Pharmacol 2012; 75:716727.
This review focuses on the potential neuroprotective effects of cocoa flavonoids
with special emphasis on brain activity, mood, and cognition.
15. Decarli C. Cerebrovascular disease: assessing the brain as an end-organ of
vascular disease. Nat Rev Cardiol 2012; 9:435436.
16. Scholey AB, French SJ, Morris PJ, et al. Consumption of cocoa flavonols
results in acute improvements in mood and cognitive performance during
sustained mental effort. J Psychopharmacol 2010; 24:15051514.
17. Sathyapalan T, Beckett S, Rigby AS, et al. High cocoa polyphenol rich
chocolate may reduce the burden of the symptoms in chronic fatigue
syndrome. Nutr J 2010; 9:55.

1363-1950 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

www.co-clinicalnutrition.com

673

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Functional foods and dietary supplements


18. Pase MP, Scholey AB, Pipingas A, et al. Cocoa polyphenols enhance positive
mood states but not cognitive performance: a randomized, placebo-controlled
trial. J Psychopharmacol 2013; 27:451.
First randomized, controlled trial to verify the effects of cocoa polyphenols on
positive mood states in a nonclinical sample comprising healthy participants.
19. Vignes M, Maurice T, Lante F, et al. Anxiolytic properties of green tea
polyphenol ( )-epigallocatechin gallate (EGCG). Brain Res 2006; 1110:
102115.
20. Martorell P, Bataller E, Llopis S, et al. A cocoa peptide protects Caenorhab&&
ditis elegans from oxidative stress and b-amyloid peptide toxicity. PLoS ONE
2013; 8:e63283.
In this study, a new bioactive peptide obtained from cocoa capable of reducing
amyloid-b peptide toxicity in an animal model of Alzheimers disease was discovered.
21. Messerli FH. Chocolate consumption cognitive function and Nobel laureates.
&&
N Engl J Med 2012; 367:15621564.
First study to show significant linear correlation between chocolate consumption
per capita and the number of Nobel laureates in various countries.
22. Camfield DA, Scholey A, Pipingas A, et al. Steady state visually evoked
&
potential (SSVEP) topography changes associated with cocoa flavanol consumption. Physiol Behav 2012; 105:948957.
It is a randomized, double-blind, placebo-controlled trial that shows increased
neural efficiency in spatial working memory function with chronic cocoa flavanol
consumption.
23. Phelps ME, Barrio JR. Correlation of brain amyloid with aerobic glycolysis: a
question of assumptions? Proc Natl Acad Sci USA 2010; 107:17459
17460.
24. Chou JL, Shenoy DV, Thomas N, et al. Early dysregulation of the mitochondrial
proteome in a mouse model of Alzheimers disease. J Proteomics 2011;
74:466479.
25. Cimini A, Gentile R, DAngelo B, et al. Cocoa powder triggers neuro&&
protective and preventive effects in a human Alzheimers disease model
by modulating BDNF signaling pathway. J Cell Biochem 2013; 114:2209
2220.
First study to jump to cellular level in in-vitro human model of Alzheimers disease
and established how cocoa work to protect the brain on a cellular level.
26. Schindowski K, Belarbi K, Buee L. Neurotrophic factors in Alzheimers
disease: role of axonal transport. Genes Brain Behav 2008; 7:4356.
27. Larsson SC, Virtamo J, Wolk A. Chocolate consumption and risk of stroke: a
&
prospective cohort of men and meta-analysis. Neurology 2013; 80:1173
1174.
First study to report the association between chocolate consumption and risk of
stroke in men. Previous studies have investigated this association; either in women
only or in men and women both.
28. Buijsse B, Weikert C, Drogan D, et al. Chocolate consumption in relation to
blood pressure and risk of cardiovascular disease in German adults. Eur Heart
J 2010; 31:16161623.
&&

674

www.co-clinicalnutrition.com

29. Larsson SC, Virtamo J, Wolk A. Chocolate consumption and risk of stroke in
women. J Am Coll Cardiol 2011; 58:18281829.
30. Castell M, Franch A, Ramos-Romero S, et al. Effect of a diet rich in cocoa
flavonoids on experimental acute inflammation. In: Keller RB, editor. Flavonoids; biosynthesis, biological effects and dietary sources, 1st ed. Hauppauge: Nova Science Publishers, Inc.; 2009. pp. 213229.
31. Vazquez-Agell M, Urpi-Sarda M, Sacanella E, et al. Cocoa consumption
&
reduces NF-kB activation in peripheral blood mononuclear cells in humans.
Nutr Metab Cardiovasc Dis 2013; 23:257263.
First in-vivo study to show inhibition of NF-kB caused by a single dose of cocoa in
healthy participants.
32. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009; 27:693733.
33. Rodrguez-Ramiro I, Ramos S, Lopez-Oliva E, et al. Cocoa polyphenols
&
prevent inflammation in the colon of azoxymethane-treated rats and in
TNF-a-stimulated Caco-2 cells. Br J Nutr 2013; 110:206215.
First study to elucidate the molecular mechanism involved in cocoa-induced
repression of intestinal inflammation in a rat model of colon carcinogenesis.
34. Golomb BA, Koperski S, White HL. Association between more frequent
&&
chocolate consumption and lower body mass index. Arch Intern Med 2012;
172:519521.
This study shows that the frequency of chocolate consumption is significantly
related to lower BMI after adjusting for age and sex.
35. Villarreal F (2010). Chocolate: an exercise mimetic? Southwest Chapter
American College of Sports Medicine Annual Meeting. San Diego, CA.
36. Nogueira L, Ramirez-Sanchez I, Perkins GA, et al. ( )-Epicatechin enhances
fatigue resistance and oxidative capacity in mouse muscle. J Physiol 2011;
589:46154631.
37. Yamashitaa Y, Okabe M, Natsume M, Ashida H. Prevention mechanisms of
&
glucose intolerance and obesity by cacao liquor procyanidin extract in high-fat
diet-fed C57BL/6 mice. Arch Biochem Biophys 2012; 527:95104.
First study to reveal downstream signaling pathways at molecular level behind
cocoa-induced amelioration of hyperglycemia, obesity, and insulin resistance.
38. Viollet B, Foretz M, Guigas B, et al. Activation of AMP-activated protein kinase
in the liver: a new strategy for the management of metabolic hepatic disorders.
J Physiol 2006; 574:4153.
39. Gu Y, Hurst WJ, Stuart DA, Lambert JD. Inhibition of key digestive enzymes by
cocoa extracts and procyanidins. J Agric Food Chem 2011; 59:53055311.
40. Gu Y, Yu S, Lambert JD. Dietary cocoa ameliorates obesity-related inflamma&
tion in high fat-fed mice. Eur J Nutr 2013. [Epub ahead of print]
This study investigated the effects of cocoa supplementation on obesity-related
inflammation, insulin resistance, and fatty liver disease.
41. Min SY, Yang H, Seo SG, et al. Cocoa polyphenols suppress adipogenesis in
&
vitro and obesity in vivo by targeting insulin receptor. Int J Obes 2013;
37:584592. [Epub ahead of print].
This study gives evidence that cocoa inhibits early stage of adipogenesis in
preadipocytes by reducing insulin receptor kinase activity via direct binding.

Volume 16  Number 6  November 2013

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Potrebbero piacerti anche